Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LA SCCHN”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Early research (Phase 1)Study completedNCT02586207
What this trial is testing

Pembrolizumab in Combination With CRT for LA-SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+4 more
Sanford Health 59
Testing effectiveness (Phase 2)Study completedNCT01181401
What this trial is testing

InductionChemo-Radio-Antibody-Treatment

Who this might be right for
Squamous Cell Carcinoma of the HeadSquamous Cell Carcinoma of the Neck
Charite University, Berlin, Germany 94
Early research (Phase 1)Study completedNCT02537223
What this trial is testing

Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLocoregionally Advanced
University Health Network, Toronto 9
Not applicableEnded earlyNCT01303237
What this trial is testing

A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckLA SCCHN
Merck KGaA, Darmstadt, Germany 88
Testing effectiveness (Phase 2)Looking for participantsNCT06959108
What this trial is testing

Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310771
What this trial is testing

Sintilimab-Nimotuzumab Induction Followed by Chemoradiation-Nimotuzumab in LA-HNSCC: Single-Arm Phase II

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-SCCHN)
Fujian Cancer Hospital 23
Large-scale testing (Phase 3)Ended earlyNCT05386550
What this trial is testing

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

Who this might be right for
Head and Neck Cancer
EMD Serono Research & Development Institute, Inc. 166
Testing effectiveness (Phase 2)UnknownNCT02753140
What this trial is testing

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 60
Early research (Phase 1)Ended earlyNCT06056310
What this trial is testing

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

Who this might be right for
Head and Neck Cancer
EMD Serono Research & Development Institute, Inc. 18
Large-scale testing (Phase 3)Active Not RecruitingNCT02999087
What this trial is testing

Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 707
Large-scale testing (Phase 3)Ended earlyNCT05930938
What this trial is testing

Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 19
Early research (Phase 1)Study completedNCT02381535
What this trial is testing

Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin

Who this might be right for
Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more
National Cancer Institute (NCI) 2